SAFETY AND EFFICACY OF INDAPAMIDE SUSTAINED RELEASE/AMLODIPINE FIXED-DOSE COMBINATION IN ESSENTIAL HYPERTENSION

被引:2
|
作者
Bricout-Hennel, S. [1 ]
Zelveian, P. [2 ]
Nedogoda, S. [3 ]
机构
[1] IRIS Cardiovasc Ctr Therapeut Innovat, Suresnes, France
[2] Inst Cardiol, Yerevan, Armenia
[3] Volgograd State Med Univ, Minist Hlth & Social, State Inst Higher Profess Educ, Volgograd, Russia
关键词
D O I
10.1097/01.hjh.0000539081.92227.69
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:E45 / E45
页数:1
相关论文
共 50 条
  • [21] Efficacy and safety of Losartan in combination with indapamide in the elderly with essential hypertension
    Zheng, H.-L.
    Wu, J.-Y.
    Chinese Pharmaceutical Journal, 2001, 36 (06) : 420 - 421
  • [22] Antihypertensive efficacy and safety of fixed-dose combination therapy with losartan plus hydrochlorothiazide in Japanese patients with essential hypertension
    Saruta, Takao
    Ogihara, Toshio
    Matsuoka, Hiroaki
    Suzuki, Hiromichi
    Toki, Megumi
    Hirayama, Yukio
    Nonaka, Kenji
    Takahashi, Kihito
    HYPERTENSION RESEARCH, 2007, 30 (08) : 729 - 739
  • [23] Antihypertensive Efficacy and Safety of Fixed-Dose Combination Therapy with Losartan plus Hydrochlorothiazide in Japanese Patients with Essential Hypertension
    Takao Saruta
    Toshio Ogihara
    Hiroaki Matsuoka
    Hiromichi Suzuki
    Megumi Toki
    Yukio Hirayama
    Kenji Nonaka
    Kihito Takahashi
    Hypertension Research, 2007, 30 : 729 - 739
  • [24] Consensi - A Fixed-Dose Combination of Amlodipine and Celecoxib
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1593): : 39 - 40
  • [25] Efficacy of a new single-pill combination of a thiazide-like diuretic and a calcium channel blocker (indapamide sustained release/amlodipine) in essential hypertension
    Dominiczak, Anna F.
    de Champvallins, Martine
    Brzozowska-Villatte, Romualda
    Asmar, Roland
    JOURNAL OF HYPERTENSION, 2019, 37 (11) : 2280 - 2289
  • [26] ANTIHYPERTENSIVE EFFICACY OF A TRIPLE FIXED-DOSE COMBINATION OF PERINDOPRIL, INDAPAMIDE, AND AMLODIPINE: CLINICAL EFFECTIVENESS IN AMBULATORY PRACTICE (RESULTS OF THE PETRA STUDY)
    Privalova, E., V
    Lishuta, A. S.
    KARDIOLOGIYA, 2018, 58 (11) : 63 - 71
  • [27] Evaluation of the Efficacy and Tolerability of Fixed-Dose Combination Therapy of Azilsartan and Amlodipine Besylate in Japanese Patients With Grade I to II Essential Hypertension
    Rakugi, Hiromi
    Nakata, Emi
    Sasaki, Emma
    Kagawa, Tomoya
    CLINICAL THERAPEUTICS, 2014, 36 (05) : 711 - 721
  • [28] Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination
    Fuwa, Masahiro
    Ueda, Kenji
    Akaishi, Takahiro
    Yamashita, Naoko
    Kirihara, Tomoko
    Shimazaki, Atsushi
    Mano, Hidetoshi
    Kawazu, Kouichi
    PLOS ONE, 2016, 11 (07):
  • [29] Economic evaluation of olmesartan/amlodipine fixed-dose combination for hypertension treatment in China
    Ren, Maodong
    Xuan, Dennis
    Lu, Yongji
    Fu, YuYan
    Xuan, Jianwei
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (04) : 394 - 400
  • [30] A growing evidence base for the fixed-dose combination of bisoprolol and amlodipine to manage hypertension
    Hostalek-Gottwald, Ulrike
    Gaciong, Zbigniew
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (07) : 1047 - 1053